Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
An organization that describes itself as being “comprised of dozens of national, public health, patient advocacy and multicultural organizations,” but [...] …
The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...] …
An influential California newspaper recently urged against a November ballot measure, which would require certain healthcare providers in the state [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
The head of an influential 340B hospital advocacy group claimed “victory” in the recent fight against Johnson & Johnson’s (J&J) [...] …
Editor’s Note: An earlier version of this story incorrectly suggested that an Oct. 4 update to 340B ESP’s terms of [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
The leader of a right-leaning think tank that’s received funding from the drug industry criticized pushback that led Johnson & [...] …
Members of Congress are headed back to their districts this week to campaign ahead of the November elections without unveiling [...] …